greeksoup/ stock research
Stock research / United States / RDY / Year to 31 March 2018

Dr. Reddy’s Laboratories Limited (RDY) annual results, year to 31 March 2018: revenue INR 142,028 million, from the 20-F

Dr. Reddy’s Laboratories Limited files a 20-F with the SEC once a year, in Indian rupees. In the year to 31 March 2018 it reported revenue of INR 142,028 million ($2.2 billion at the year's average rate), up 0.9% on the year before. Its profit attributable to shareholders was INR 9,806 million, down 18.5%, and diluted earnings per share INR 59.00.

Revenue
INR 142,028 million
+0.9% on the year
FY2016FY2018
Operating margin
8.4%
9.6% a year earlier
FY2016FY2018
Net income
INR 9,806 million
-18.5% on the year
FY2016FY2018
Diluted EPS
INR 59.00
-18.2% on the year
FY2016FY2018

this yearthe year beforeIn Indian rupees as filed. Hover a bar for its figure.

Income statement (profit and loss)

Year toMar 2017Mar 2018 †
Revenue140,809142,028
Cost of sales62,45365,724
Gross profit78,35676,304
Research and development19,55118,265
Selling, general and administrative46,37246,857
Operating profit13,49811,917
Finance costs781817
Profit before tax14,65314,341
Income tax2,6144,535
Profit for the year12,0399,806
Profit attributable to shareholders12,0399,806
Filing20-F20-F
INR million, from the 20-F on the SEC's EDGAR, linked in the last row, on the IFRS tags the company filed.
Read moreA line the company does not file under the standard tag is left out rather than estimated.
Year toMar 2017Mar 2018 †
Diluted EPS72.0959.00
Basic EPS72.2459.13
Filing20-F20-F

INR per ordinary share, as filed.

Cash flow

Year toMar 2017Mar 2018 †
Cash from operations21,51318,029
Purchase of property, plant and equipment12,2789,291
Free cash flow9,2358,738
Cash from investing-18,471-14,883
Cash from financing-3,692-4,440
Depreciation and amortisation11,27711,710
Buybacks15,6940.0
Dividends paid3,3903,992
Filing20-F20-F

INR million. Free cash flow is cash from operations less the purchase of property, plant and equipment, arithmetic on the two filed lines.

Balance sheet

Year toMar 2017Mar 2018 †
Funded by
Equity attributable to shareholders124,044126,460
Borrowings, as filed49,09850,618
Other liabilities46,67948,526
Total equity and liabilities219,821225,604
Owned
Property, plant and equipment57,16057,869
Goodwill3,7523,945
Other intangible assets44,92544,665
Cash and cash equivalents3,8662,638
Trade and other receivables38,06540,617
Inventories28,52929,089
Other assets43,52446,781
Total assets219,821225,604
Filing20-F20-F

INR million, at each fiscal year end.

Ratios on the filed lines

Year toMar 2017Mar 2018 †
Gross margin55.6%53.7%
Operating margin9.6%8.4%
Net margin8.5%6.9%
Free cash flow margin6.6%6.2%
Return on year-end equity9.7%7.8%
Effective tax rate17.8%31.6%
Filing20-F20-F

Arithmetic on the filed lines of the same year.

20-F for the year to 31 March 2018, filed 15 June 2020: the filing. The figures are in Indian rupees as filed.